Correction to: "Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study". . J Clin Endocrinol Metab 2024 Dec 17:dgae870. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: "Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study". J Clin Endocrinol Metab 2024 Dec 17:dgae870. doi: 10.1210.
PMID: 39688662